Cellular Mechanisms of Inflammation, Hemostasis, and Thrombosis
Cellular Mechanisms of Inflammation, Hemostasis, and Thrombosis
批准号:
10229365
负责人:
Mark HOWARD Ginsberg
金额:
$234.03万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-08-05 至 2025-07-31
关键词:
AdhesivesAdultBloodBlood PlateletsBlood VesselsCCM1 geneCell AdhesionCell physiologyCell-Cell AdhesionCellsCollaborationsComplexDevelopmentEndothelial CellsEndotheliumEventGene SilencingGenesGeneticGlassHeartHemostatic functionHumanIndividualInflammationLeukocyte Adhesion DeficiencyLeukocytesLightMethodsMicrofluidicsMolecularMolecular ConformationMusMutatePharmacologyPhysiologicalPlayPrevention strategyProcessRegulationResearch PersonnelResistanceResolutionRoleSignal TransductionStructural BiologistStructureSurfaceTalinTestingTherapeuticThrombosisTranslationsUbiquitinationVascular Diseasesadhesion receptordesignexperiencefeasibility testingimaging modalityimproved outcomein vivoin vivo Modelmouse modelneutrophilnovelnovel diagnosticsnovel therapeutic interventionoptogeneticsplatelet functionprogramsprotein protein interactionresponse
中文摘要
摘要
需要为跨学科的努力提供支持,以了解关键的分子和
在炎症、止血中调节血液和血管细胞的发育事件
血栓形成,重点是黏附信号。这四个项目将:1)测试
假设Rap1和talin1之间的直接相互作用在
血小板、白细胞和内皮细胞在炎症、止血和治疗中的作用
血栓形成。2)使用新开发的成像方式实现定量动态
中性粒细胞与底物接触的表面足迹以评估粘附性
特异性分子接头-黏附反应中的受体聚集和构象
受体相互作用。一个特别的焦点是kindlin-3基因的结构和功能。
人类白细胞黏附缺陷3型突变及其与他林的关系。3)
早期研究人员将测试Krit1或Krit1基因失活的假设
成年小鼠体内的Heg1可以预防实验性炎症或血栓形成。在……里面
与结构生物学家合作,他将延长研究,以测试
药物干扰HEG1-KRIT1复合体以模拟遗传效应
这些基因的失活。4)评估夏平及其合作伙伴的作用
LUBAC线性泛素化复合体在血小板和
内皮细胞与炎症、止血和血栓形成。该项目将测试
假设这种新发现的血小板和内皮细胞功能调节因子
有助于炎症、止血和血栓形成。一个科学核心单位,由一个
炎症、止血和血栓形成小鼠模型的世界领先者,将提供
具有活体模型和专业知识的单个项目需要建立病理-
这些新的分子机制的生理学相关性。
英文摘要
ABSTRACT
Support is requested for an interdisciplinary effort to understand the key molecular and
developmental events that regulate blood and vascular cells in inflammation, hemostasis
and thrombosis with a focus on adhesive signaling. The four Projects will: 1) Test the
hypothesis that direct interactions between Rap1 and talin1 plays an important role in
platelet, leukocyte, and endothelial cell functions in inflammation, hemostasis and
thrombosis. 2) Use newly developed imaging modalities to enable quantitative dynamic
footprinting of the surface of neutrophils in contact with substrate to assess adhesion
receptor clustering and conformation in response to specific molecular adaptor-adhesion
receptor interactions. A particular focus is the structure-function of kindlin-3, the gene
mutated in human leukocyte adhesion deficiency Type 3, and its relationship to talin. 3)
An Early Stage Investigator will test the hypothesis that genetic inactivation of Krit1 or
Heg1 in adult mice will protect against experimental inflammation or thrombosis. In
collaboration with a structural biologist, he will extend studies to test the feasibility of
pharmacologically disrupting the HEG1-KRIT1 complex to mimic the effects of genetic
inactivation of these genes. 4) To assess the role of SHARPIN and associated
components of the LUBAC linear ubiquitination complex in the functions of platelets and
endothelial cells in inflammation, hemostasis, and thrombosis. This project will test the
hypothesis that this newly-identified regulator of platelet and endothelial cell functions
contributes to inflammation, hemostasis, and thrombosis. A scientific core unit, led by a
world leader in murine models of inflammation, hemostasis, and thrombosis, will provide
the individual projects with in vivo models and expertise required to establish the patho-
physiological relevance of these novel molecular mechanisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Direct Rap1-talin interaction in platelets, leukocytes, and endothelial cells
-
批准号:10229368
-
项目类别:
-
资助金额:$48.79万
-
财政年份:2020
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Cellular Mechanisms of Inflammation, Hemostasis, and Thrombosis
-
批准号:10676869
-
项目类别:
-
资助金额:$233.35万
-
财政年份:2020
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Core B - Ginsberg-ADMINISTRATIVE CORE
-
批准号:10229366
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2020
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Core B - Ginsberg-ADMINISTRATIVE CORE
-
批准号:10676887
-
项目类别:
-
资助金额:$7.86万
-
财政年份:2020
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Direct Rap1-talin interaction in platelets, leukocytes, and endothelial cells
-
批准号:10676892
-
项目类别:
-
资助金额:$48.69万
-
财政年份:2020
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Deconvoluting the Vascular Adhesome
-
批准号:10327637
-
项目类别:
-
资助金额:$78.7万
-
财政年份:2018
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Deconvoluting the Vascular Adhesome
-
批准号:10548841
-
项目类别:
-
资助金额:$78.7万
-
财政年份:2018
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Anti-Coagulant and Cytoprotective activity in CCM pathogenesis
-
批准号:10417155
-
项目类别:
-
资助金额:$31.45万
-
财政年份:2015
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Anti-Coagulant and Cytoprotective activity in CCM pathogenesis
-
批准号:10621253
-
项目类别:
-
资助金额:$31.38万
-
财政年份:2015
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Anti-Coagulant and Cytoprotective activity in CCM pathogenesis
-
批准号:10220146
-
项目类别:
-
资助金额:$31.52万
-
财政年份:2015
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Composition and Functions of the Integrin Activation Complex
-
批准号:8695078
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Project 4: A Binary Switch in Adhesion Maturation
-
批准号:8234230
-
项目类别:
-
资助金额:$26.99万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Administrative Core
-
批准号:8256553
-
项目类别:
-
资助金额:$9.43万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
KRIT1 and Vascular Integrity
-
批准号:8038085
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Activation of B3 Integrins
-
批准号:8256548
-
项目类别:
-
资助金额:$47.35万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
KRIT1 and Vascular Integrity
-
批准号:8207881
-
项目类别:
-
资助金额:$38.69万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
KRIT1 and Vascular Integrity
-
批准号:8605067
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
KRIT1 and Vascular Integrity
-
批准号:8402853
-
项目类别:
-
资助金额:$36.89万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Activation of B3 Integrins
-
批准号:7995808
-
项目类别:
-
资助金额:$47.89万
-
财政年份:2010
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Administrative Core
-
批准号:7995819
-
项目类别:
-
资助金额:$9.45万
-
财政年份:2010
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
海外基金